chr15:90083045:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr15:90,626,277-90,645,709 |
hg38 | chr15:90,083,045-90,102,477 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
<0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
<0.001 | chondroblastoma | Specific H3F3A driver mutations and IDH2 mutations were recently described in gi... | BeFree | 26457357 | Detail |
0.002 | chondrosarcoma | Here, we identified the spectrum of IDH mutations in human enchondromas and chon... | BeFree | 25730874 | Detail |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
<0.001 | colorectal carcinoma | The study of OxPhos-related genes revealed that an imbalance between the express... | BeFree | 25586680 | Detail |
0.241 | Enchondromatosis | Mutant IDH is sufficient to initiate enchondromatosis in mice. | BeFree,CTD_human,ORPHANET | 25730874 | Detail |
0.120 | hemangioma | NA | BeFree,CTD_human | Detail | |
0.005 | Hematological Disease | NA | BeFree,GAD | Detail | |
<0.001 | hepatitis | The frequencies of KRAS and IDHs mutations, which are associated with poor disea... | BeFree | 25636086 | Detail |
<0.001 | hepatitis A | The frequencies of KRAS and IDHs mutations, which are associated with poor disea... | BeFree | 25636086 | Detail |
0.121 | Angioimmunoblastic Lymphadenopathy | Although IDH2 mutations are largely confined to AITL, mutations of the other 3 c... | BeFree,CTD_human | 26268241 | Detail |
<0.001 | Vulvar Lichen Sclerosus | NA | BeFree | Detail | |
0.004 | leukemia | Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyg... | BeFree | 25398939 | Detail |
0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.036 | Leukemia, Myelocytic, Acute | Firstly, by analyzing biomarkers associated with AML, to assist normal clinical ... | BeFree,GAD | 24867525 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Patients with acute myeloid leukemia (AML) frequently harbor mutations in genes ... | BeFree,GAD | 24986689 | Detail |
0.036 | Leukemia, Myelocytic, Acute | In conclusion, our study showed a high frequency of FLT3, RUNX1, and IDH mutatio... | BeFree,GAD | 25022553 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Mutations of IDH1 and IDH2, which produce the oncometabolite 2-hydroxyglutarate ... | BeFree,GAD | 25398940 | Detail |
0.036 | Leukemia, Myelocytic, Acute | These data provide a role for WT1 in regulating DNA hydroxymethylation and sugge... | BeFree,GAD | 25482556 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Overall, our data suggest that IDH mutations are rare in the preleukemic disorde... | BeFree,GAD | 25486927 | Detail |
0.036 | Leukemia, Myelocytic, Acute | IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wi... | BeFree,GAD | 25599133 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Here we report that WT1, a sequence-specific transcription factor, is mutated in... | BeFree,GAD | 25601757 | Detail |
0.036 | Leukemia, Myelocytic, Acute | IDH1 and IDH2 mutations may predict a favorable response to DNMTI in patients wi... | BeFree,GAD | 25651001 | Detail |
0.036 | Leukemia, Myelocytic, Acute | IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways i... | BeFree,GAD | 25795706 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Characteristics, clinical outcome, and prognostic significance of IDH mutations ... | BeFree,GAD | 26016821 | Detail |
0.036 | Leukemia, Myelocytic, Acute | Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acu... | BeFree,GAD | 26111463 | Detail |
0.036 | Leukemia, Myelocytic, Acute | As the genetic landscape of AML has been mapped, other attractive targets for th... | BeFree,GAD | 26111466 | Detail |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
0.002 | Leukemia, Myelomonocytic, Chronic | NA | GAD | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.002 | Lung Neoplasms | NA | GAD | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
0.121 | Maffucci syndrome | NA | BeFree,ORPHANET | Detail | |
<0.001 | paroxysmal nocturnal hemoglobinuria | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree | 25486927 | Detail |
0.003 | melanoma | NA | BeFree,GAD | Detail | |
<0.001 | Metabolic Diseases | NA | BeFree | Detail | |
<0.001 | muscular dystrophy | NA | BeFree | Detail | |
<0.001 | myelofibrosis | NA | BeFree | Detail | |
<0.001 | Acute Myeloid Leukemia, M1 | NA | BeFree | Detail | |
0.005 | Myeloproliferative disease | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
0.003 | Neoplasm Metastasis | NA | BeFree,GAD | Detail | |
0.120 | Degenerative polyarthritis | NA | CTD_human | Detail | |
0.120 | osteoporosis | NA | CTD_human | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
<0.001 | paraganglioma | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | IDH1 and IDH2 mutations are found in many neoplasms, and germline alterations in... | BeFree | 25766404 | Detail |
0.003 | polycythemia vera | NA | BeFree,GAD | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.010 | Preleukemia | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
<0.001 | retinitis pigmentosa | NA | BeFree | Detail | |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
0.003 | Thrombocythemia, Essential | NA | BeFree,GAD | Detail | |
0.121 | peripheral T-cell lymphoma | Although IDH2 mutations are largely confined to AITL, mutations of the other 3 c... | BeFree,CTD_human | 26268241 | Detail |
<0.001 | Central Nervous System Neoplasms | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Bone Cysts, Aneurysmal | Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and ... | BeFree | 26457357 | Detail |
<0.001 | Malignant neoplasm of brain | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumor of Bone | Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and ... | BeFree | 26457357 | Detail |
0.122 | cholangiocarcinoma | Exome and the following prevalence sequencing identified mutations of the BAP1, ... | BeFree,CTD_human | 24532422 | Detail |
<0.001 | ganglioglioma | NA | BeFree | Detail | |
<0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | Lesion of brain | NA | BeFree | Detail | |
<0.001 | Telangiectatic osteosarcoma | Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and ... | BeFree | 26457357 | Detail |
<0.001 | Erythroblastosis | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | Solid tumour | The role of mutant IDH in controlling hepatic differentiation state suggests the... | BeFree | 25485496 | Detail |
<0.001 | high-grade childhood cerebral astrocytoma | NA | BeFree | Detail | |
0.120 | mixed oligodendroglioma-astrocytoma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree,ORPHANET | 25853694 | Detail |
0.122 | anaplastic astrocytoma | IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation ... | BeFree,ORPHANET | 25962792 | Detail |
0.120 | protoplasmic astrocytoma | NA | ORPHANET | Detail | |
0.120 | gemistocytic astrocytoma | NA | ORPHANET | Detail | |
0.120 | fibrillary astrocytoma | NA | ORPHANET | Detail | |
<0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
0.001 | intrahepatic cholangiocarcinoma | In line with these findings, human ICC with IDH mutations are characterized by a... | BeFree | 25485496 | Detail |
0.002 | Hematologic Neoplasms | IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wi... | BeFree | 25599133 | Detail |
0.120 | Anaplastic Oligoastrocytoma | NA | ORPHANET | Detail | |
<0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
<0.001 | Chondrogenic Neoplasm | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
0.002 | Malignant glioma | NA | BeFree | Detail | |
0.001 | Leukemogenesis | Overall, our data suggest that IDH mutations are rare in the preleukemic disorde... | BeFree | 25486927 | Detail |
0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
0.001 | Acute lymphocytic leukemia | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
<0.001 | Myeloid Leukemia, Chronic | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
0.003 | Primary myelofibrosis | We have studied the mutational status of TET2 (complete coding region), ASXL1 (e... | BeFree | 21904853 | Detail |
0.003 | polycythemia vera | We have studied the mutational status of TET2 (complete coding region), ASXL1 (e... | BeFree | 21904853 | Detail |
<0.001 | bile duct carcinoma | NA | BeFree | Detail | |
<0.001 | germ cell cancer | NA | BeFree | Detail | |
<0.001 | biliary tract cancer | IDH mutations in liver cell plasticity and biliary cancer. | BeFree | 25485496 | Detail |
<0.001 | Brain Tumor, Primary | Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes suggest ... | BeFree | 25727224 | Detail |
<0.001 | Chromosome 10, monosomy 10q | NA | BeFree | Detail | |
<0.001 | dedifferentiated chondrosarcoma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Cardiomyopathies | NA | BeFree | Detail | |
0.120 | chondroma | NA | BeFree,CTD_human | Detail | |
<0.001 | Intestinal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | sarcoma | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree | 25486927 | Detail |
<0.001 | spindle cell hemangioma | NA | BeFree | Detail | |
<0.001 | Astrocytoma, low grade | NA | BeFree | Detail | |
<0.001 | adult astrocytic tumors | NA | BeFree | Detail | |
<0.001 | Conventional Chondrosarcoma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Vascular lesions | NA | BeFree | Detail | |
<0.001 | Primary Glioblastoma | The large majority of lower-grade gliomas without an IDH mutation had genomic ab... | BeFree | 26061751 | Detail |
0.001 | Secondary Glioblastoma | NA | BeFree | Detail | |
<0.001 | colorectal cancer | The study of OxPhos-related genes revealed that an imbalance between the express... | BeFree | 25586680 | Detail |
<0.001 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
<0.001 | Enchondroma | Taken together, these data show that mutant IDH or d-2HG causes persistence of c... | BeFree | 25730874 | Detail |
<0.001 | Enchondroma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
0.001 | D-2-hydroxyglutaric aciduria | NA | BeFree | Detail | |
0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
0.001 | low grade glioma | Surgically treated incidentally discovered low-grade gliomas are mostly IDH muta... | BeFree | 25674227 | Detail |
<0.001 | liver carcinoma | Our results for the first time suggest that IDH gene polymorphisms may serve as ... | BeFree | 25355558 | Detail |
<0.001 | liver carcinoma | We identified 7 SNPs in SDHC, SDHD, FH, and IDH2 genes to be significantly assoc... | BeFree | 25894340 | Detail |
0.121 | combined D-2- and L-2-hydroxyglutaric aciduria | NA | BeFree,CTD_human | Detail | |
0.120 | Glioma susceptibility 1 | NA | UNIPROT | Detail | |
<0.001 | D-2-hydroxyglutaric aciduria 1 | NA | BeFree | Detail | |
0.010 | myelodysplastic syndrome | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
0.002 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
0.003 | Primary myelofibrosis | NA | BeFree,GAD | Detail | |
<0.001 | aplastic anemia | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree | 25486927 | Detail |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | atherosclerosis | NA | BeFree | Detail | |
0.006 | Blast Phase | NA | BeFree,GAD | Detail | |
<0.001 | Bone neoplasms | These tumors are characterized by frequent gain-of-function mutations in the iso... | BeFree | 25485496 | Detail |
0.023 | Brain Neoplasms | We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study... | BeFree,GAD | 24366912 | Detail |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Specific H3F3A driver mutations and IDH2 mutations were recently described in giant cell tumor of bo... | DisGeNET | Detail |
Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and stud... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The study of OxPhos-related genes revealed that an imbalance between the expression of IDH1 and IDH2... | DisGeNET | Detail |
Mutant IDH is sufficient to initiate enchondromatosis in mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The frequencies of KRAS and IDHs mutations, which are associated with poor disease-free survival, we... | DisGeNET | Detail |
The frequencies of KRAS and IDHs mutations, which are associated with poor disease-free survival, we... | DisGeNET | Detail |
Although IDH2 mutations are largely confined to AITL, mutations of the other 3 can be found in other... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Firstly, by analyzing biomarkers associated with AML, to assist normal clinical tests, we confirmed ... | DisGeNET | Detail |
Patients with acute myeloid leukemia (AML) frequently harbor mutations in genes involved in the DNA ... | DisGeNET | Detail |
In conclusion, our study showed a high frequency of FLT3, RUNX1, and IDH mutations in AML-M0, sugges... | DisGeNET | Detail |
Mutations of IDH1 and IDH2, which produce the oncometabolite 2-hydroxyglutarate (2HG), have been ide... | DisGeNET | Detail |
These data provide a role for WT1 in regulating DNA hydroxymethylation and suggest that TET2 IDH1/ID... | DisGeNET | Detail |
Overall, our data suggest that IDH mutations are rare in the preleukemic disorders and may not be th... | DisGeNET | Detail |
IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wild-type cells to ABT... | DisGeNET | Detail |
Here we report that WT1, a sequence-specific transcription factor, is mutated in a mutually exclusiv... | DisGeNET | Detail |
IDH1 and IDH2 mutations may predict a favorable response to DNMTI in patients with AML. | DisGeNET | Detail |
IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leuk... | DisGeNET | Detail |
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML. | DisGeNET | Detail |
Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia. | DisGeNET | Detail |
As the genetic landscape of AML has been mapped, other attractive targets for therapy have been disc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IDH1 and IDH2 mutations are found in many neoplasms, and germline alterations in SDH genes and FH pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although IDH2 mutations are largely confined to AITL, mutations of the other 3 can be found in other... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and IDH2 mutations in GC... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and IDH2 mutations in GC... | DisGeNET | Detail |
Exome and the following prevalence sequencing identified mutations of the BAP1, ARID1A, IDH1 and IDH... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and IDH2 mutations in GC... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of mutant IDH in controlling hepatic differentiation state suggests the potential of newly ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little differenc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In line with these findings, human ICC with IDH mutations are characterized by a hepatic progenitor ... | DisGeNET | Detail |
IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wild-type cells to ABT... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overall, our data suggest that IDH mutations are rare in the preleukemic disorders and may not be th... | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132),... | DisGeNET | Detail |
We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IDH mutations in liver cell plasticity and biliary cancer. | DisGeNET | Detail |
Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes suggest a role for this abno... | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The large majority of lower-grade gliomas without an IDH mutation had genomic aberrations and clinic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The study of OxPhos-related genes revealed that an imbalance between the expression of IDH1 and IDH2... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving ... | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-del... | DisGeNET | Detail |
Our results for the first time suggest that IDH gene polymorphisms may serve as an independent progn... | DisGeNET | Detail |
We identified 7 SNPs in SDHC, SDHD, FH, and IDH2 genes to be significantly associated with the RFS o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These tumors are characterized by frequent gain-of-function mutations in the isocitrate dehydrogenas... | DisGeNET | Detail |
We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study the expression of H... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr15:90,083,045-90,102,477
- Variant Type
- snv
Genome browser